PHATHOM PHARMACEUTICALS INC's ticker is PHAT and the CUSIP is 71722W107. A total of 95 filers reported holding PHATHOM PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2,756,280 | +19.9% | 245,658 | +18.4% | 0.04% | +7.7% |
| Q3 2022 | $2,298,000 | +35.8% | 207,428 | +3.5% | 0.04% | +50.0% |
| Q2 2022 | $1,692,000 | -39.8% | 200,423 | -3.0% | 0.03% | -27.8% |
| Q1 2022 | $2,812,000 | -41.5% | 206,607 | -15.5% | 0.04% | -35.7% |
| Q4 2021 | $4,808,000 | -12.7% | 244,439 | +42.5% | 0.06% | -17.6% |
| Q3 2021 | $5,505,000 | -5.1% | 171,506 | +0.1% | 0.07% | -1.4% |
| Q2 2021 | $5,801,000 | – | 171,376 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 2,067,861 | $40,675,000 | 10.18% |
| FRAZIER MANAGEMENT LLC | 5,827,415 | $114,625,000 | 8.82% |
| Abingworth LLP | 1,203,135 | $23,606,000 | 5.72% |
| RA Capital Management | 3,115,008 | $61,272,000 | 1.08% |
| Avidity Partners Management LP | 1,896,000 | $37,294,000 | 0.79% |
| StepStone Group LP | 422,085 | $8,302,000 | 0.47% |
| Summit Rock Advisors, LP | 34,100 | $671,000 | 0.40% |
| Parkman Healthcare Partners LLC | 77,481 | $1,524,000 | 0.34% |
| Rhenman & Partners Asset Management AB | 186,210 | $3,624,000 | 0.24% |
| Ikarian Capital, LLC | 74,560 | $1,467,000 | 0.22% |